Humanitas Mirasole SpA

Humanitas Mirasole SpA is a company in Rozzano (Mi), Italy that has taken part in 51 EU-funded projects since 2008, receiving €23.5M in EU funding and leading 19 as coordinator.

EU funding received€23.5M
EU projects51
As coordinator19
Running now18
First EU project2008
Latest project2027
CountryItaly
EU registration (PIC)999785015
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Humanitas Mirasole SpA's own share of each project, not the project's full budget.

  • Horizon 2020€10.1M · 20 projects
  • Horizon Europe€7.4M · 17 projects
  • FP7 (2007 to 2013)€6.0M · 13 projects
  • EU4Health Programme (EU4H)€79k · 1 project

Projects

51 EU-funded projects, newest first. Humanitas Mirasole SpA led 19 of them as coordinator. Each links to the official record.

  • RESIST-CCACoordinator

    Unravelling Malignant Cholangiocyte Subpopulations that Drive Chemoresistance in Cholangiocarcinoma

    Horizon Europe · 2027–2028 · Project on CORDIS ↗

    €194ktheir share
  • LUMINAPartner

    LUng Modeling and INtelligence for Advanced care: A Digital Twin Approach to Lung Cancer Diagnosis and Treatment

    Horizon Europe · 2026–2030 · Project on CORDIS ↗

    €625ktheir share
  • AI-RITMIAPartner

    AI-assisted peRsonalized heart-on-chIp as advanced diagnostic Tool for clinical significance assessMent of Inherited cArdiomyopathies

    Horizon Europe · 2026–2029 · Project on CORDIS ↗

    €557ktheir share
  • GlioZEROPartner

    Advanced technologies for zeroing in on high-grade gliomas

    Horizon Europe · 2026–2030 · Project on CORDIS ↗

    €125ktheir share
  • MDR-RAAssociated partner

    Defining Clinical and Molecular Phenotypes of Multi-Drug Resistance in difficult to treat Rheumatoid Arthritis

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

  • ECOPOPPartner

    EARLY COLORECTAL CANCER: PATIENT-TARGETED AND ORGAN PRESERVING TREATMENT ECOPOP

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

    €321ktheir share
  • PHOENIXPartner

    PHOENIX: Precision Human Organs-on-chip for Enhanced Neuro-muscular and Cardiac Studies

    Horizon Europe · 2025–2028 · Project on CORDIS ↗

    €566ktheir share
  • CarrerasPathfindersAssociated partner

    Enabling the next generation in search of blood cancer cures

    Horizon Europe · 2024–2029 · Project on CORDIS ↗

  • SYNTHIAPartner

    Synthetic Data Generation Framework for Integrated Validation of Use Cases and AI Healthcare Applications

    Horizon Europe · 2024–2029 · Project on CORDIS ↗

    €506ktheir share
  • CLAUD-ITPartner

    Clinical Audit Implementation in Europe - a practical and multidisciplinary approach

    EU4Health Programme (EU4H) · 2024–2027 · Project on the EU portal ↗

    €79ktheir share
  • PREMIO COLLABPartner

    Personalised response monitoring in oncology: co-creating clinical trials in advanced breast cancer

    Horizon Europe · 2024–2029 · Project on CORDIS ↗

    €388ktheir share
  • FIBROTARGETPartner

    Validation of novel immunotherapeutic targets against fibrosis in inflammatory bowel diseases

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

    €665ktheir share
  • MATILDACoordinator

    Microglia As conTroller of braIn metaboLism During Aging

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

    €2.5Mtheir share
  • CarrerasLeadersAssociated partner

    Carreras Postdoc Program Empowering Future Leaders to Fight Blood Cancers

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

  • SQUEEZEPartner

    Maximising Impact of Prescription Drugs in Rheumatoid Arthritis

    Horizon Europe · 2022–2027 · Project on CORDIS ↗

    €233ktheir share
  • SYNTHEMAPartner

    Synthetic generation of hematological data over federated computing frameworks

    Horizon Europe · 2022–2026 · Project on CORDIS ↗

    €453ktheir share
  • OperAPartner

    OPTIMISING COLORECTAL CANCER PREVENTION TROUGH PERSONALISED TREATMENT WITH ARTIFICIAL INTELLIGENCE

    Horizon Europe · 2022–2027 · Project on CORDIS ↗

    €250ktheir share
  • NEUROCOVAssociated partner

    The pandemic within: tackling brain vulnerability in COVID19 at high resolution: NEUROCOV

    Horizon Europe · 2022–2027 · Project on CORDIS ↗

  • Algae4IBDAssociated partner

    ALGAE4IBD –FROM NATURE TO BEDSIDE- ALGAE BASED BIO COMPOUND FOR PREVENTION AND TREATMENT OF INFLAMMATION, PAIN AND IBD

    Horizon 2020 · 2021–2026 · Project on CORDIS ↗

  • HARMONIAPartner

    Development of a Support System for Improved Resilience and Sustainable Urban areas to cope with Climate Change and Extreme Events based on GEOSS and Advanced Modelling Tools

    Horizon 2020 · 2021–2025 · Project on CORDIS ↗

    €201ktheir share
  • GenoMed4ALLPartner

    Genomics and Personalized Medicine for all though Artificial Intelligence in Haematological Diseases

    Horizon 2020 · 2021–2025 · Project on CORDIS ↗

    €713ktheir share
  • COVID-XPartner

    COVID eXponential Programme

    Horizon 2020 · 2020–2022 · Project on CORDIS ↗

    €549ktheir share
  • Pituitary enhancersCoordinator

    Identification and functional validation of novel enhancer sequences involved in pituitary gland development and pathology

    Horizon 2020 · 2020–2022 · Project on CORDIS ↗

    €183ktheir share
  • ImmUniverseAssociated partner

    Better control and treatment of immune-mediated diseases by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsies

    Horizon 2020 · 2020–2026 · Project on CORDIS ↗

  • DaPhNIsCoordinator

    Role of the Maternal Gut Microbiota in Immune Activation at the Maternal-Foetal Interface: Impact on Preeclampsia and Offspring's Immune Development

    Horizon 2020 · 2019–2021 · Project on CORDIS ↗

    €168ktheir share
  • TRAIN-HEARTPartner

    TRAIN-HEART

    Horizon 2020 · 2019–2023 · Project on CORDIS ↗

    €523ktheir share
  • SUMO-PCDH10Coordinator

    Physiological consequences of Protocadherin-10 sumoylation on neuronal function.

    Horizon 2020 · 2019–2021 · Project on CORDIS ↗

    €171ktheir share
  • LION-HEARTEDPartner

    Light and Organic Nanotechnology for Cardiovascular Disease

    Horizon 2020 · 2019–2023 · Project on CORDIS ↗

    €450ktheir share
  • BIORECARPartner

    Direct cell reprogramming therapy in myocardial regeneration through an engineered multifunctional platform integrating biochemical instructive cues

    Horizon 2020 · 2018–2025 · Project on CORDIS ↗

    €125ktheir share
  • TUDCA-ALSCoordinator

    Safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS)

    Horizon 2020 · 2018–2023 · Project on CORDIS ↗

    €1.5Mtheir share
  • MONONANOCHEMCoordinator

    In vivo engineering of monocytes loaded with nano-chemotherapeutic formulations: a novel live-cell mediated drug delivery system for the treatment of cancer

    Horizon 2020 · 2017–2018 · Project on CORDIS ↗

    €168ktheir share
  • miRCaPCoordinator

    Innovative nanoparticle formulation for a miR-133 based treatment of cardiac hypertrophy

    Horizon 2020 · 2016–2018 · Project on CORDIS ↗

    €150ktheir share
  • EDEN2020Associated partner

    Enhanced Delivery Ecosystem for Neurosurgery in 2020

    Horizon 2020 · 2016–2021 · Project on CORDIS ↗

  • ESA -ITNPartner

    European Sepsis Academy: towards new biomarkers to improve sepsis management

    Horizon 2020 · 2016–2020 · Project on CORDIS ↗

    €516ktheir share
  • MIROCALSPartner

    Efficacy and safety of low-dose IL-2 (ld-IL-2) as a Treg enhancer for anti-neuroinflammatory therapy in newly diagnosed Amyotrophic Lateral Sclerosis (ALS) patients

    Horizon 2020 · 2015–2021 · Project on CORDIS ↗

    €450ktheir share
  • PERSYSTCoordinator

    Generation and maintenance of long-lived memory T cells in humans

    Horizon 2020 · 2015–2021 · Project on CORDIS ↗

    €1.5Mtheir share
  • PHIICoordinator

    PTX3 in Humoral Innate Immunity

    Horizon 2020 · 2015–2020 · Project on CORDIS ↗

    €2.5Mtheir share
  • NANOTAMCoordinator

    Development and Evaluation of Nanomedicines for Cancer Treatment through Immunomodulation: Targeting Tumor-Associated Macrophages

    Horizon 2020 · 2015–2017 · Project on CORDIS ↗

    €168ktheir share
  • MRNA IN HEARTCoordinator

    mRNA translational regulation in heart failure

    FP7 (2007 to 2013) · 2014–2016 · Project on CORDIS ↗

    €187ktheir share
  • STEPSPartner

    Signalling compartmentalization and vesicle Trafficking at the Phagocytic Synapses

    FP7 (2007 to 2013) · 2013–2019 · Project on CORDIS ↗

    €344ktheir share
Show 11 more projects
  • CARDIOEPIGENCoordinator

    Epigenetics and microRNAs in Myocardial Function and Disease

    FP7 (2007 to 2013) · 2012–2018 · Project on CORDIS ↗

    €2.5Mtheir share
  • STEMIMMUNECoordinator

    Improving adoptive T cell transfer immunotherapy for cancer with T memory stem cells

    FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗

    €100ktheir share
  • d-LIVERPartner

    ICT-enabled, cellular artificial liver system incorporating personalized patient management and support

    FP7 (2007 to 2013) · 2011–2015 · Project on CORDIS ↗

    €36ktheir share
  • FROM BENCH TO BEDSIDECoordinator

    Role of microRNAs 143 and 145 in cardiovascular physiology and disease: from bench to bedside

    FP7 (2007 to 2013) · 2011–2015 · Project on CORDIS ↗

    €33ktheir share
  • CNKHIVCoordinator

    Characterization of NK cell distributions and functions in human tissues in HIV-1 pathogenesis

    FP7 (2007 to 2013) · 2011–2015 · Project on CORDIS ↗

    €100ktheir share
  • HSC SELF-RENEWALCoordinator

    Global microRNA profiling of normal and Pbx1-null hematopoietic stem cells and progenitors for the identification of new regulators of the balance between self-renewal and differentiation

    FP7 (2007 to 2013) · 2010–2015 · Project on CORDIS ↗

    €100ktheir share
  • ATTRACTPartner

    Advanced Teaching and TRaining for Adoptive Cell Therapy

    FP7 (2007 to 2013) · 2009–2013 · Project on CORDIS ↗

    €202ktheir share
  • HIISCoordinator

    The humoral innate immune system: long pentraxins as a paradigm

    FP7 (2007 to 2013) · 2009–2014 · Project on CORDIS ↗

    €2.1Mtheir share
  • SIPODPartner

    A Coordinated and Structured International Post-Doctoral Program to Foster Trans-national Mobility and Independent Career of Scientists in Biomedicine

    FP7 (2007 to 2013) · 2009–2014 · Project on CORDIS ↗

  • MOODINFLAMEPartner

    Early diagnosis, treatment and prevention of mood disorders targetting the activated inflammatory response system

    FP7 (2007 to 2013) · 2008–2013 · Project on CORDIS ↗

    €228ktheir share
  • RIISPADCoordinator

    Role of innate immunity in the pathogenesis of autoimmune diseases

    FP7 (2007 to 2013) · 2008–2012 · Project on CORDIS ↗

    €100ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • DNA
  • HIV
  • RNA
  • alkaline earth metals
  • amyotrophic lateral sclerosis
  • anatomy and morphology
  • arteriosclerosis
  • artificial intelligence
  • autoimmune diseases
  • bioartificial liver
  • carbohydrates
  • cardiology
  • cardiovascular diseases
  • cell biology

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime